In this section
   BioLines
 BioBusiness
Industry news
 BioLines

An archive of Cambridge Genetics Knowledge Park’s contributions to Cambridge Network’s monthly BioLines column. BioLines is a biotechnology column that provides a platform for discussion of latest advances in bioscience and related legal, ethical and social issues.

See below for article headlines and links to the full story on the Cambridge Network site.

2006

Experimental tests, informed consent and public health emergencies

EU funding of human embryonic stem cell research: the saga continues

Protection of medical information: has it gone too far?

Choices and boundaries in preimplantation genetic diagnosis

 

2005

The ethics of egg donation

Using genetics in reproductive decision-making: what do the public think?

Genomics research and global justice

Genetic profiling of newborn babies: not yet, says expert group

The Human Tissue Act: how it turned out

Stem cell ethics and regulation: thinking beyond the embryo

Freeing up the licensing of genetic inventions

Balancing crime detection and civil liberties

 

2004

Cord blood banking: guidelines and prospects

Genetic susceptibility tests - regulate vendor or caveat emptor?

Disease and the treatment/enhancement distinction

Assessing the public's views on genetics and reproductive decision-making

The Human Tissue Bill and the Mental Capacity Bill: the struggle to legitimise useful research

The vexed question of genetics and insurance

Barcode babies: prospects for genetic profiling

Guidance on best practice in the management of research databases

In search of cancer signatures

You are what you eat? The promise of nutrigenetics and nutrigenomics

Pharmacogenetics in cancer: when will we see the benefits?

The new Human Tissue Bill - solving some problems by creating others?

 

2003

EU funding of stem cell research: will the battle soon be resolved?

Genning up on genetics in the health service

The Cambridge Genetics Knowledge Park

 

 

search